{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T05:14:03Z","timestamp":1770700443105,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,4,18]],"date-time":"2010-04-18T00:00:00Z","timestamp":1271548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s11064-010-0168-5","type":"journal-article","created":{"date-parts":[[2010,4,17]],"date-time":"2010-04-17T02:22:15Z","timestamp":1271470935000},"page":"1156-1163","source":"Crossref","is-referenced-by-count":19,"title":["Glycolysis Inhibition Decreases the Levels of Glutamate Transporters and Enhances Glutamate Neurotoxicity in the R6\/2 Huntington\u2032s Disease Mice"],"prefix":"10.1007","volume":"35","author":[{"given":"Ana Mar\u00eda","family":"Estrada-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Montiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Massieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,18]]},"reference":[{"key":"168_CR1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"168_CR2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.3155875","volume":"227","author":"GA Graveland","year":"1985","unstructured":"Graveland GA, Williams RS, DiFiglia M (1985) Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington\u2019s disease. Science 227:770\u2013773","journal-title":"Science"},{"key":"168_CR3","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ et al (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"168_CR4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/263517a0","volume":"263","author":"EG McGeer","year":"1976","unstructured":"McGeer EG, McGeer PL (1976) Duplication of biochemical changes of Huntington\u2019s chorea by intrastriatal injections of glutamic and kainic acids. Nature 263:517\u2013519","journal-title":"Nature"},{"key":"168_CR5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.6849138","volume":"219","author":"R Schwarcz","year":"1983","unstructured":"Schwarcz R, Whetsell WO, Mangano RM (1983) Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219:316\u2013318","journal-title":"Science"},{"key":"168_CR6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00005072-199704000-00013","volume":"56","author":"T Arzberger","year":"1997","unstructured":"Arzberger T, Krampfl K, Leimgruber S et al (1997) Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT-1) mRNA expression in Huntington\u2019s disease-an in situ hybridization study. J Neuropathol Exp Neurol 56:440\u2013454","journal-title":"J Neuropathol Exp Neurol"},{"key":"168_CR7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.0953-816X.2000.01379.x","volume":"13","author":"B Nicniocaill","year":"2001","unstructured":"Nicniocaill B, Haraldsson B, Hansson O et al (2001) Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6\/1 Huntington transgenic mice. Eur J Neurosci 13:206\u2013210","journal-title":"Eur J Neurosci"},{"key":"168_CR8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","volume":"8","author":"JC Li\u00e9vens","year":"2001","unstructured":"Li\u00e9vens JC, Woodman B, Mahal A et al (2001) Impaired glutamate uptake in the R6 Huntington\u2019s disease transgenic mice. Neurobiol Dis 8:807\u2013821","journal-title":"Neurobiol Dis"},{"key":"168_CR9","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/brain\/awf180","volume":"125","author":"PF Behrens","year":"2002","unstructured":"Behrens PF, Franz P, Woodman B et al (2002) Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain 125:1908\u20131922","journal-title":"Brain"},{"key":"168_CR10","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","volume":"171","author":"JY Shin","year":"2005","unstructured":"Shin JY, Fang ZH, Yu ZX et al (2005) Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 171:1001\u20131012","journal-title":"J Cell Biol"},{"key":"168_CR11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s11064-007-9463-1","volume":"33","author":"B Hassel","year":"2008","unstructured":"Hassel B, Tessler S, Faull RL et al (2008) Glutamate uptake is reduced in prefrontal cortex in Huntington\u2019s disease. Neurochem Res 33:232\u2013237","journal-title":"Neurochem Res"},{"key":"168_CR12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neuroscience.2008.02.004","volume":"153","author":"BR Miller","year":"2008","unstructured":"Miller BR, Dorner JL, Shou M et al (2008) Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington\u2019s disease phenotype in the R6\/2 mouse. Neuroscience 153:329\u2013337","journal-title":"Neuroscience"},{"key":"168_CR13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.nbd.2008.12.017","volume":"34","author":"AM Estrada-S\u00e1nchez","year":"2009","unstructured":"Estrada-S\u00e1nchez AM, Montiel T, Segovia J et al (2009) Glutamate toxicity in the striatum of the R6\/2 Huntington\u2019s disease transgenic mice is age\u2013dependent and correlates with decreased levels of glutamate transporters. Neurobiol Dis 34:78\u201386","journal-title":"Neurobiol Dis"},{"key":"168_CR14","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00004647-200110000-00001","volume":"21","author":"D Attwell","year":"2001","unstructured":"Attwell D, Laughlin SB (2001) An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab 21:1133\u20131145","journal-title":"J Cereb Blood Flow Metab"},{"key":"168_CR15","doi-asserted-by":"crossref","first-page":"10625","DOI":"10.1073\/pnas.91.22.10625","volume":"91","author":"L Pellerin","year":"1994","unstructured":"Pellerin L, Magistretti PJ (1994) Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci USA 91:10625\u201310629","journal-title":"Proc Natl Acad Sci USA"},{"key":"168_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jcbfm.1994.1","volume":"14","author":"RA Swanson","year":"1994","unstructured":"Swanson RA, Chen J, Graham SH (1994) Glucose can fuel glutamate uptake in ischemic brain. J Cereb Blood Flow Metab 14:1\u20136","journal-title":"J Cereb Blood Flow Metab"},{"key":"168_CR17","doi-asserted-by":"crossref","first-page":"7337","DOI":"10.1523\/JNEUROSCI.23-19-07337.2003","volume":"23","author":"A Loaiza","year":"2003","unstructured":"Loaiza A, Porras OH, Barros LF (2003) Glutamate triggers rapid glucose transport stimulation in astrocytes as evidenced by real-time confocal microscopy. J Neurosci 23:7337\u20137342","journal-title":"J Neurosci"},{"key":"168_CR18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0006-8993(99)02022-3","volume":"850","author":"R Debernardi","year":"1999","unstructured":"Debernardi R, Magistretti PJ, Pellerin L (1999) Trans-inhibition of glutamate transport prevents excitatory amino acid-induced glycolysis in astrocytes. Brain Res 850:39\u201346","journal-title":"Brain Res"},{"key":"168_CR19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/00004647-200104000-00009","volume":"21","author":"N Cholet","year":"2001","unstructured":"Cholet N, Pellerin L, Welker E et al (2001) Local injection of antisense oligonucleotides targeted to the glial glutamate transporter GLAST decreases the metabolic response to somatosensory activation. J Cereb Blood Flow Metab 21:404\u2013412","journal-title":"J Cereb Blood Flow Metab"},{"key":"168_CR20","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0306-4522(94)90523-1","volume":"63","author":"T Gemba","year":"1994","unstructured":"Gemba T, Oshima T, Ninomiya M (1994) Glutamate efflux via the reversal of the sodium-dependent glutamate transporter caused by glycolytic inhibition in rat cultured astrocytes. Neuroscience 63:789\u2013795","journal-title":"Neuroscience"},{"key":"168_CR21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/BF01705543","volume":"20","author":"T Ogata","year":"1995","unstructured":"Ogata T, Nakamura Y, Tsuji K et al (1995) A possible mechanism for the hypoxia-hypoglycemia-induced release of excitatory amino acids from cultured hippocampal astrocytes. Neurochem Res 20:737\u2013743","journal-title":"Neurochem Res"},{"key":"168_CR22","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.neuroscience.2006.07.004","volume":"142","author":"A Camacho","year":"2006","unstructured":"Camacho A, Montiel T, Massieu L (2006) The anion channel blocker, 4, 4\u2019-dinitrostilbene-2, 2\u2019-disulfonic acid prevents neuronal death and excitatory amino acid release during glycolysis inhibition in the hippocampus in vivo. Neuroscience 142:1005\u20131017","journal-title":"Neuroscience"},{"key":"168_CR23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/jnr.20631","volume":"82","author":"K Hern\u00e1ndez-Fonseca","year":"2005","unstructured":"Hern\u00e1ndez-Fonseca K, Massieu L (2005) Disruption of endoplasmic reticulum calcium stores is involved in neuronal death induced by glycolysis inhibition in cultured hippocampal neurons. J Neurosci Res 82:196\u2013205","journal-title":"J Neurosci Res"},{"key":"168_CR24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0306-4522(03)00266-5","volume":"120","author":"L Massieu","year":"2003","unstructured":"Massieu L, Haces ML, Montiel T et al (2003) Acetoacetate protects hippocampal neurons against glutamate-mediated neuronal damage during glycolysis inhibition. Neuroscience 120:365\u2013378","journal-title":"Neuroscience"},{"key":"168_CR25","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1471-4159.1971.tb00013.x","volume":"18","author":"MI Sabri","year":"1971","unstructured":"Sabri MI, Ochs S (1971) Inhibition of glyceraldehyde-3-phosphate dehydrogenase in mammalian nerve by iodoacetic acid. J Neurochem 18:1509\u20131514","journal-title":"J Neurochem"},{"key":"168_CR26","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/jnr.21634","volume":"86","author":"K Hern\u00e1ndez-Fonseca","year":"2008","unstructured":"Hern\u00e1ndez-Fonseca K, C\u00e1rdenas-Rodr\u00edguez N, Pedraza-Chaverri J et al (2008) Calcium-dependent production of reactive oxygen species is involved in neuronal damage induced during glycolysis inhibition in cultured hippocampal neurons. J Neurosci Res 86:1768\u20131780","journal-title":"J Neurosci Res"},{"key":"168_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/neuro.14.001.2009","volume":"1","author":"MM Schmidt","year":"2009","unstructured":"Schmidt MM, Dringen R (2009) Differential effects of iodoacetamide and iodoacetate on glycolysis and glutathione metabolism of cultured astrocytes. Front Neuroenergetics 1:1\u201310","journal-title":"Front Neuroenergetics"},{"key":"168_CR28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbt.20278","volume":"23","author":"N C\u00e1rdenas-Rodr\u00edguez","year":"2009","unstructured":"C\u00e1rdenas-Rodr\u00edguez N, Guzm\u00e1n-Beltr\u00e1n S, Medina-Campos ON et al (2009) The effect of nordihydroguaiaretic acid on iodoacetate-induced toxicity in cultured neurons. J Biochem Mol Toxicol 23:137\u2013142","journal-title":"J Biochem Mol Toxicol"},{"key":"168_CR29","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.neuroscience.2006.12.069","volume":"30","author":"A Camacho","year":"2007","unstructured":"Camacho A, Montiel T, Massieu L (2007) Sustained metabolic inhibition induces an increase in the content and phosphorylation of the NR2B subunit of N-methyl-D-aspartate receptors and a decrease in glutamate transport in the rat hippocampus in vivo. Neuroscience 30:873\u2013886","journal-title":"Neuroscience"},{"key":"168_CR30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1006\/exnr.2000.7481","volume":"165","author":"L Massieu","year":"2000","unstructured":"Massieu L, G\u00f3mez-Rom\u00e1n N, Montiel T (2000) In vivo potentiation of glutamate-mediated neuronal damage after chronic administration of the glycolysis inhibitor iodoacetate. Exp Neurol 165:257\u2013267","journal-title":"Exp Neurol"},{"key":"168_CR31","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s11064-006-9189-5","volume":"31","author":"J Mej\u00eda-Toiber","year":"2006","unstructured":"Mej\u00eda-Toiber J, Montiel T, Massieu L (2006) D-beta-hydroxybutyrate prevents glutamate-mediated lipoperoxidation and neuronal damage elicited during glycolysis inhibition in vivo. Neurochem Res 31:1399\u20131408","journal-title":"Neurochem Res"},{"key":"168_CR32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1471-4159.1997.69010285.x","volume":"69","author":"RT Matthews","year":"1997","unstructured":"Matthews RT, Ferrante RJ, Jenkins BG et al (1997) Iodoacetate produces striatal excitotoxic lesions. J Neurochem 69:285\u2013289","journal-title":"J Neurochem"},{"key":"168_CR33","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jnr.490130403","volume":"13","author":"M Sandberg","year":"1985","unstructured":"Sandberg M, Nystr\u00f6m B, Hamberger A (1985) Metabolically derived aspartate-elevated extracellular levels in vivo in iodoacetate poisoning. J Neurosci Res 13:489\u2013495","journal-title":"J Neurosci Res"},{"key":"168_CR34","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1073\/pnas.0609833104","volume":"104","author":"WJ Powers","year":"2007","unstructured":"Powers WJ, Videen TO, Markham J et al (2007) Selective defect of in vivo glycolysis in early Huntington\u2019s disease striatum. Proc Natl Acad Sci USA 104:2945\u20132949","journal-title":"Proc Natl Acad Sci USA"},{"key":"168_CR35","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/WNL.50.5.1357","volume":"50","author":"BG Jenkins","year":"1998","unstructured":"Jenkins BG, Rosas HD, Chen YC et al (1998) 1H NMR spectroscopy studies of Huntington\u2019s disease: correlations with CAG repeat numbers. Neurology 50:1357\u20131365","journal-title":"Neurology"},{"key":"168_CR36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nm0396-347","volume":"2","author":"JR Burke","year":"1996","unstructured":"Burke JR, Enghild JJ, Martin ME et al (1996) Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Med 2:347\u2013350","journal-title":"Nat Med"},{"key":"168_CR37","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1073\/pnas.0511316103","volume":"103","author":"BI Bae","year":"2006","unstructured":"Bae BI, Hara MR, Cascio MB et al (2006) Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDH. Proc Natl Acad Sci USA 103:3405\u20133409","journal-title":"Proc Natl Acad Sci USA"},{"key":"168_CR38","volume-title":"The mouse brain in stereotaxic coordinates","author":"G Paxinos","year":"2004","unstructured":"Paxinos G, Franklin KJ (2004) The mouse brain in stereotaxic coordinates. Elsevier Academic Press, San Diego"},{"key":"168_CR39","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254","journal-title":"Anal Biochem"},{"key":"168_CR40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1044-7431(02)00013-1","volume":"22","author":"VV Senatorov","year":"2003","unstructured":"Senatorov VV, Charles V, Reddy PH et al (2003) Overexpression and nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase in a transgenic mouse model of Huntington\u2019s disease. Mol Cell Neurosci 22:285\u2013297","journal-title":"Mol Cell Neurosci"},{"key":"168_CR41","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/archneur.55.10.1299","volume":"55","author":"SJ Kish","year":"1998","unstructured":"Kish SJ, Lopes-Cendes I, Guttman M et al (1998) Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders. Arch Neurol 55:1299\u20131304","journal-title":"Arch Neurol"},{"key":"168_CR42","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","volume":"41","author":"SE Browne","year":"1997","unstructured":"Browne SE, Bowling AC, MacGarvey U et al (1997) Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: selective vulnerability of the basal ganglia. Ann Neurol 41:646\u2013653","journal-title":"Ann Neurol"},{"key":"168_CR43","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1159\/000017344","volume":"20","author":"AJ Cooper","year":"1998","unstructured":"Cooper AJ, Sheu KF, Burke JR et al (1998) Glyceraldehyde-3-phosphate dehydrogenase abnormality in metabolically stressed Huntington disease fibroblasts. Dev Neurosci 20:462\u2013468","journal-title":"Dev Neurosci"},{"key":"168_CR44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0361-9230(00)00238-0","volume":"52","author":"AJ Morton","year":"2000","unstructured":"Morton AJ, Leavens W (2000) Mice transgenic for the human Huntington\u2019s disease mutation have reduced sensitivity to kainic acid toxicity. Brain Res Bull 52:51\u201359","journal-title":"Brain Res Bull"},{"key":"168_CR45","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/jnr.10100","volume":"67","author":"GA MacGibbon","year":"2002","unstructured":"MacGibbon GA, Hamilton LC, Crocker SF et al (2002) Immediate-early gene response to methamphetamine, haloperidol, and quinolinic acid is not impaired in Huntington\u2019s disease transgenic mice. J Neurosci Res 67:372\u2013378","journal-title":"J Neurosci Res"},{"key":"168_CR46","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.0953-816x.2001.01767.x","volume":"14","author":"O Hansson","year":"2001","unstructured":"Hansson O, Guatteo E, Mercuri NB et al (2001) Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene. Eur J Neurosci 14:1492\u20131504","journal-title":"Eur J Neurosci"},{"key":"168_CR47","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1111\/j.1460-9568.2004.03633.x","volume":"7","author":"TS Tang","year":"2004","unstructured":"Tang TS, Tu H, Orban PC et al (2004) HAP1 facilitates effects of mutant huntingtin on inositol 1, 4, 5-trisphosphate-induced Ca release in primary culture of striatal medium spiny neurons. Eur J Neurosci 7:1779\u20131787","journal-title":"Eur J Neurosci"},{"key":"168_CR48","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.brainres.2004.06.005","volume":"1019","author":"J Schiefer","year":"2004","unstructured":"Schiefer J, Spr\u00fcnken A, Puls C et al (2004) The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington\u2019s disease. Brain Res 1019:246\u2013254","journal-title":"Brain Res"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-010-0168-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-010-0168-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-010-0168-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:36:16Z","timestamp":1559349376000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-010-0168-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,18]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["168"],"URL":"https:\/\/doi.org\/10.1007\/s11064-010-0168-5","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,18]]}}}